Fentanyl (Fentanyl Fresenius, Fetanyl Fresenius)
Fentanyl
Fresenius Kabi Manufacturing SA (Pty) Ltd
Registration
- Applicant
- Fresenius Kabi Manufacturing SA (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Fentanyl 100 mcg/2 ML fresenius EACH 2,0 ml AMPOULE CONTAINS FENTANYL CITRATE EQUIVALENT TO 100,0 ug FENTANYL BASE | 100 mcg/2 ml | W0123W/2.9/123 | Registered | Not determined | None |
| Fetanyl 500 mcg/10 ML fresenius EACH 10 ml CONTAINS FENTANYL CITRATE EQUIVALENT TO 500 ug FENTANYL BASE | 500 mcg/10 ml | X0260X/2.7/260 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S6: Fentanyl
- when intended for therapeutic purposes.
Consolidated Schedules 06 July 2026, line 10256
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Drag to rotate. Structure from PubChem CID 3345.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.